Hepcidin Regulation by BMP Signaling in Macrophages Is Lipopolysaccharide Dependent

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Wu, Xinggang ^a   Yung, Lai Ming ^c   Cheng, Wai Hang ^a   Yu, Paul B ^c   Babitt, Jodie L ^c   Lin, Herbert Y ^c   Xia, Yin ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; HEPCIDIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF DIFFERENTIATION 1; LIPOPOLYSACCHARIDE; PROTEIN INHIBITOR; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; INTRACELLULAR SIGNALING; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION;

BACTERIA (MICROORGANISMS);

EID: 84866382685     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044622     Document Type: Article

References (38)

1. Krause A, Neitz S, Mägert H-J, Schulz A, Forssmann W-G, et al. (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Letters 480: 147-150 doi:10.1016/S0014-5793(00)01920-7.
2. Park CH, Valore EV, Waring AJ, Ganz T, (2001) Hepcidin, a Urinary Antimicrobial Peptide Synthesized in the Liver. Journal of Biological Chemistry 276: 7806-7810 doi:10.1074/jbc.M008922200.
3. Ganz T, (2009) Iron in innate immunity: starve the invaders. Curr Opin Immunol 21: 63-67 doi:10.1016/j.coi.2009.01.011.
4. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, et al. (2003) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101: 2461-2463 doi:10.1182/blood-2002-10-3235.
5. Lee P, Peng H, Gelbart T, Beutler E, (2004) The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and beta 2-microglobulin-deficient hepatocytes. Proc Natl Acad Sci USA 101: 9263-9265 doi:10.1073/pnas.0403108101.
6. Lee P, Peng H, Gelbart T, Wang L, Beutler E, (2005) Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proceedings of the National Academy of Sciences of the United States of America 102: 1906-1910 doi:10.1073/pnas.0409808102.
7. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, et al. (2006) Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38: 531-539 doi:10.1038/ng1777.
8. Wang R-H, Li C, Xu X, Zheng Y, Xiao C, et al. (2005) A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2: 399-409 doi:10.1016/j.cmet.2005.10.010.
9. Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, et al. (2007) Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest 117: 1933-1939 doi:10.1172/JCI31342.
10. Xia Y, Babitt JL, Sidis Y, Chung RT, Lin HY, (2008) Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood 111: 5195-5204 doi:10.1182/blood-2007-09-111567.
11. Andriopoulos B, Corradini E, Xia Y, Faasse SA, Chen S, et al. (2009) BMP-6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 41: 482-487 doi:10.1038/ng.335.
12. Shi Y, Massagué J, (2003) Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus. Cell 113: 685-700 doi:10.1016/S0092-8674(03)00432-X.
13. Korchynskyi O, ten Dijke P, (2002) Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter. Journal of Biological Chemistry 277: 4883-4891 doi:10.1074/jbc.M111023200.
14. Truksa J, Peng H, Lee P, Beutler E, (2006) Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proceedings of the National Academy of Sciences 103: 10289-10293 doi:10.1073/pnas.0603124103.
15. Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, et al. (2009) Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet 41: 478-481 doi:10.1038/ng.320.
16. Steinbicker AU, Bartnikas TB, Lohmeyer LK, Leyton P, Mayeur C, et al. (2011) Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice. Blood 118: 4224-4230 doi:10.1182/blood-2011-03-339952.
17. Liu X-B, Nguyen N-BH, Marquess KD, Yang F, Haile DJ, (2005) Regulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages. Blood Cells Mol Dis 35: 47-56 doi:10.1016/j.bcmd.2005.04.006.
18. Peyssonnaux C, Zinkernagel AS, Datta V, Lauth X, Johnson RS, et al. (2006) TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 107: 3727-3732 doi:10.1182/blood-2005-06-2259.
19. Nguyen N-B, Callaghan KD, Ghio AJ, Haile DJ, Yang F, (2006) Hepcidin expression and iron transport in alveolar macrophages. American Journal of Physiology- Lung Cellular and Molecular Physiology 291: L417-L425 doi:10.1152/ajplung.00484.2005.
20. Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, et al. (2007) Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. Journal of Leukocyte Biology 82: 934-945 doi:10.1189/jlb.0407216.
21. Theurl I, Theurl M, Seifert M, Mair S, Nairz M, et al. (2008) Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 111: 2392-2399 doi:10.1182/blood-2007-05-090019.
22. Sow FB, Alvarez GR, Gross RP, Satoskar AR, Schlesinger LS, et al. (2009) Role of STAT1, NF-κB, and C/EBPβ in the macrophage transcriptional regulation of hepcidin by mycobacterial infection and IFN-γ. Journal of Leukocyte Biology 86: 1247-1258 doi:10.1189/jlb.1208719.
23. Wu S, Zhang K, Lv C, Wang H, Cheng B, et al. (2011) Nuclear factor-kB mediated lipopolysaccharide-induced mRNA expression of hepcidin in human peripheral blood leukocytes. Innate Immun 18: 318-324 Available: http://www.ncbi.nlm.nih.gov/pubmed/21685415. Accessed 2012 Jan 6.
24. Wang L, Harrington L, Trebicka E, Shi HN, Kagan JC, et al. (2009) Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. J Clin Invest 119: 3322-3328 doi:10.1172/JCI39939.
25. Lee GT, Kwon SJ, Lee J-H, Jeon SS, Jang KT, et al. (2010) Induction of interleukin-6 expression by bone morphogenetic protein-6 in macrophages requires both SMAD and p38 signaling pathways. J Biol Chem 285: 39401-39408 doi:10.1074/jbc.M110.103705.
26. Xia Y, Cortez-Retamozo V, Niederkofler V, Salie R, Chen S, et al. (2011) Dragon (repulsive guidance molecule b) inhibits IL-6 expression in macrophages. J Immunol 186: 1369-1376 doi:10.4049/jimmunol.1002047.
27. Swinney DC, Xu Y-Z, Scarafia LE, Lee I, Mak AY, et al. (2002) A small molecule ubiquitination inhibitor blocks NF-kappa B-dependent cytokine expression in cells and rats. J Biol Chem 277: 23573-23581 doi:10.1074/jbc.M200842200.
28. Pinto JP, Dias V, Zoller H, Porto G, Carmo H, et al. (2010) Hepcidin messenger RNA expression in human lymphocytes. Immunology 130: 217-230 doi:10.1111/j.1365-2567.2009.03226.x.
29. Song S-NJ, Tomosugi N, Kawabata H, Ishikawa T, Nishikawa T, et al. (2010) Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. Blood 116: 3627-3634 doi:10.1182/blood-2010-03-271791.
30. Wrighting DM, Andrews NC, (2006) Interleukin-6 induces hepcidin expression through STAT3. Blood 108: 3204-3209 doi:10.1182/blood-2006-06-027631.
31. Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, et al. (2007) STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109: 353-358 doi:10.1182/blood-2006-07-033969.
32. Truksa J, Lee P, Beutler E, (2009) Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness. Blood 113: 688-695 doi:10.1182/blood-2008-05-160184.
33. Kwon SJ, Lee GT, Lee J-H, Kim WJ, Kim IY, (2009) Bone morphogenetic protein-6 induces the expression of inducible nitric oxide synthase in macrophages. Immunology 128: e758-765 doi:10.1111/j.1365-2567.2009.03079.x.
34. Qin H, Wang L, Feng T, Elson CO, Niyongere SA, et al. (2009) TGF-beta promotes Th17 cell development through inhibition of SOCS3. J Immunol 183 (1):: 97-105.
35. Bleuming SA, Kodach LL, Garcia Leon MJ, Richel DJ, Peppelenbosch MP, et al. (2006) Altered bone morphogenetic protein signalling in the Helicobacter pylori-infected stomach. J Pathol 209: 190-197 doi:10.1002/path.1976.
36. Derwall M, Malhotra R, Lai CS, Beppu Y, Aikawa E, et al. (2012) Inhibition of Bone Morphogenetic Protein Signaling Reduces Vascular Calcification and Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 32: 613-622 Available:http://www.ncbi.nlm.nih.gov/pubmed/22223731. Accessed 20 January 2012.
37. Yu PB, Deng DY, Lai CS, Hong CC, Cuny GD, et al. (2008) BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med 14: 1363-1369 doi:10.1038/nm.1888.
38. Fukuda T, Kohda M, Kanomata K, Nojima J, Nakamura A, et al. (2009) Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. J Biol Chem 284: 7149-7156 doi:10.1074/jbc.M801681200.